SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging following a blowout earnings report characterized by massive data center growth and strong AI infrastructure demand, with analysts aggressively raising price targets. The community is buzzing with excitement over the stock's parabolic move, fueling intense debate between retail bulls celebrating a "generational" trend and skeptics pointing to soaring valuation multiples and signs of market irrationality.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market sentiment surrounding the Invesco QQQ Trust remains intensely bullish, driven by strong earnings momentum in the semiconductor sector and widespread speculation regarding potential peace talks in the Middle East. Community discourse is highly polarized, with many investors riding the rapid upward trajectory while a vocal segment warns of a potential bubble given the swift pace of recent gains.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 continues to rally as markets react to headlines regarding a potential pause in U.S. military efforts in the Strait of Hormuz, with community sentiment deeply polarized between bullish momentum traders chasing AI-driven gains and bearish voices citing concerns over valuation, inflation, and the legitimacy of recent geopolitical announcements.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Investors are actively debating the recent stagnation of NVDA while competitors surge, with many speculating that heavy institutional pinning and capital rotation are suppressing the stock ahead of upcoming earnings. Despite the broader AI sector momentum, the community remains divided between those viewing the current price action as a strategic buying opportunity and those concerned that the stock is losing leadership to memory and CPU-focused chipmakers.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as retail and institutional investors pile into the stock, fueled by unprecedented demand for memory chips in AI data centers and ongoing excitement over new high-capacity product announcements. While the community is debating whether this parabolic rally represents a sustainable shift in memory sector fundamentals or a classic bubble, many investors are actively discussing potential stock splits and aggressive price targets as Micron hits new highs.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Semiconductor investors are engaged in a high-stakes standoff as the market's relentless momentum drives the sector to historic valuation levels, leaving those positioned for a reversal frustrated by persistent after-hours gains. The community is actively debating the sustainability of this melt-up, with many expressing skepticism over disconnected earnings and recycled headlines while others warn that the aggressive nature of leveraged ETFs makes timing a correction particularly dangerous.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive, parabolic price surge driven by severe NAND flash and DRAM supply shortages, with AI data center demand keeping the memory supercycle in high gear through at least 2027. The community is sharply divided, with bulls celebrating life-changing gains and betting on structural market dominance, while skeptical bears warn of a classic bubble fueled by extreme valuation disconnects and speculative euphoria.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending after a significant surge in after-hours trading driven by an earnings beat and strong margin recovery, which has largely eased concerns regarding profitability and prior accounting-related overhangs. The community is actively debating the stock's potential for a massive short squeeze given high short interest, while some remain cautious about management's communication style and ongoing institutional skepticism despite the company's robust data center infrastructure growth.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is rallying following a landmark 10-year AI data center contract with Cerebras Systems, fueling community optimism about a significant valuation gap and potential for future expansion. While retail investors are actively sharing bullish targets and calling for a short squeeze, some market participants remain cautious due to the stock's historical volatility and speculative nature.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors pivot toward the potential of its oral Wegovy pipeline, with community sentiment shifting positively following reports of manufacturing scale and a widening efficacy gap between its oral franchise and competitors' small-molecule alternatives. The conversation is primarily focused on the upcoming earnings report and the strategic launch of the Ozempic tablet, with many anticipating that strong volume data will validate a reversal in the stock's recent downtrend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Barclays analyst Tom O'Malley raised the firm's price target on Arm to $200 from $165 and kept an ‘Overweight’ rating on the shares.</li><li>RBC Capital said that Arm’s much-anticipated full-chip strategy will complement its IP business.</li><li>Arm on Tuesday had announced that it is extending into&nbsp;the&nbsp;production of silicon products for the first time in its history.&nbsp;</li></ul>Shares of Arm Holdings (ARM) closed 16% higher on Wednesday as several analysts were buoyed by the company's outlook as well as its first company-designed data center CPU.&nbsp;Arm on Tuesday had announced that it is extending into&nbsp;the production of silicon products for the first time in its history with the launch of the Arm AGI CPU, an Arm-designed CPU for AI data centers, built to address a rising class of agentic AI workloads.Arm CEO Rene Haas reportedly told Bloomberg in an interview on Tuesday that the company expects its own chips business to generate about $15 billion in annual sales in five years. Meta Platforms (META) will be the first major customer for the company's new AGI CPU chip.<h2 class="st-heading-2">Bullish Wall Street</h2>Raymond James&nbsp;subsequently upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's announced business model shift to include a fabless semiconductor element for the upgrade, per TheFly.&nbsp;Barclays analyst Tom O'Malley raised the firm's price target on Arm to $200 from $165 and kept an ‘Overweight’ rating on the shares. The "Arm Everywhere" event made it clear that CPUs play a very important role in agentic AI and the company's solution is the AGI CPU, which "plays to ARM's strength in energy efficiency," the analyst told investors.RBC Capital also raised the firm's price target on Arm to $175 from $130 and kept an ‘Outperform’ rating on the shares. The firm cited the company's much-anticipated full-chip strategy, which the management believes will complement its IP business, the analyst told investors in a research note. The strategy offers significant revenue growth and earnings potential over the long term but comes with gross margin dilution and channel conflict issues, RBC Capital added.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around ARM trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have risen 39% so far in 2026.&nbsp;

The replica of the ARM is an electronic chip board during a collaborative ceremony launching a partnership between Malaysia and ARM Holdings in Kuala Lumpur, Malaysia, on March 5, 2025. 

Why Did Arm Stock Close 16% Higher Today?

Raymond James upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's business model shift to include a fabless semiconductor element for the upgrade.

Equity

Raymond James upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's business model shift to include a fabless semiconductor element for the upgrade.


<ul class="summary-bullets"><li>BTIG reiterated a ‘Buy’ rating and $70 price target on On Holding.</li><li>Telsey Advisory analyst Cristina Fernandez lowered the firm's price target on On Holding to $60 from $65.</li><li>Co-founder Olivier Bernhard will continue spearheading key performance product initiatives and athlete engagement as an Executive Member of the Board.</li></ul>ON Holdings (<a href="https://stocktwits.com/symbol/ONON">ONON</a>) shares were down nearly 11% on Wednesday after its CEO Martin Hoffmann&nbsp;stepped down from his role,&nbsp;bringing the stock into analysts' focus.&nbsp;Telsey Advisory analyst Cristina Fernandez lowered the firm's price target on On Holding to $60 from $65 and kept an ‘Outperform’ rating on the shares.BTIG reiterated a ‘Buy’ rating and $70 price target on On Holding. After speaking with the company, the firm said it does not believe the change in leadership is reflective of any challenges in the current business, but rather a transition that coincides with its next phase of growth currently being formulated and Hoffmann's desire to pursue more personal interests.&nbsp;Management stressed this decision is not correlated with how the current business is doing and their excitement regarding the year ahead is "as high as ever," the analyst told investors in a research note.<h2 class="st-heading-2">New Co-CEOs</h2>The company said that David Allemann and Caspar Coppetti will assume the roles of Co-CEOs, while continuing as Executive Co-Chairmen of the Board. Co-founder Olivier Bernhard will continue spearheading key performance product initiatives and athlete engagement as an Executive Member of the Board.“With the strategic roadmap for continued growth in place, the four partners collectively recognize that this is the right moment for Martin Hoffmann to step down,” the company said in regards to Hoffman’s stepping down.&nbsp;<h2 class="st-heading-2">Retail reaction</h2>Retail sentiment around ONON trended in ‘extremely bullish’ territory amid ‘high’ message volume.Shares in the company have fallen 25% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of On Holding AG (NYSE: ONON), a Swiss sportswear company known for its high-performance running shoes and apparel. 

ONON Stock Falls After Surprise CEO Resignation Leaves Wall Street Divided

The company said that David Allemann and Caspar Coppetti will assume the roles of Co-CEOs, while continuing as Executive Co-Chairmen of the Board.

<ul class="summary-bullets"><li>Amid rumors, the companies confirmed the deal to WSJ early Friday.&nbsp;</li><li>Unilever’s food business is said to be worth tens of billions of dollars, and the deal with McCormick would involve only stock and no cash - WSJ source.</li><li>Stocktwits sentiment for UL and MKC ‘bullish.’</li></ul>U.S.-listed shares of Unilever PLC jumped 2.3% in early premarket trading on Friday, amid news of a restructuring involving its food business.The packaged goods giant plans to separate its foods business, which includes Knorr soups, Hellmann’s mayonnaise and Lipton tea, among other items, and combine it with spice&nbsp;maker&nbsp;McCormick, the companies&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/business/deals/unilever-in-talks-to-separate-food-business-and-combine-it-with-mccormick-212091ae">confirmed</a> to the Wall Street Journal.&nbsp;McCormick shares rose 1% in Friday’s premarket session.<h2 class="st-heading-2">Unilever Sharpen Focus On Beauty, Personal Care</h2>The major strategy shift by Unilever would continue a trend of consumer conglomerates streamlining their businesses and would leave U.K.-based Unilever focused on beauty, personal-care products and home, the Journal reported.Unilever’s food business is said to be worth tens of billions of dollars, and the deal with McCormick would involve only stock and no cash, the Journal reported, citing information from a source.Maryland-based McCormick, known for its bottled spices and brands like French’s yellow mustard, is set to report its first-quarter results on March 31.On Stocktwits, retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/UL">UL</a> and&nbsp;<a href="https://stocktwits.com/symbol/MKC">MKC</a> was ‘bullish’ early Friday.<h2 class="st-heading-2">Consumer Conglomerates Eye Deals&nbsp;</h2>Trian Fund Management’s Nelson Peltz joined Unilever’s board in 2022 after the hedge fund took a big stake in the company. The activist investor was previously a director at Unilever rival Procter &amp; Gamble, and has a record of pushing for splits and reconfigurations of sprawling conglomerates.Unilever spun off its ice cream business, Magnum Ice Cream, last year. In 2021, the company made unsolicited approaches to GlaxoSmithKline’s consumer-health unit but backed off the idea the following year.Kraft Heinz last year unveiled plans to split into separate companies, reflecting a broader “<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/business/retail/kraft-heinz-is-splitting-into-two-companies-2b632fa7?mod=article_inline">conglomerate breakup</a>” trend gaining traction across the consumer sector.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/smci-stock-cracks-premarket-on-alleged-nvidia-chip-diversion-to-china-super-micro-nvda-stress-compliance/cZ3XjzQRIh6">SMCI Stock Cracks Premarket On Alleged Nvidia Chip Diversion To China; Super Micro, NVDA Stress Compliance</a>&nbsp;

Hellmann's Mayonnaise seen at a supermarket. (Photo by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

UL, MKC Stocks Jump Premarket: McCormick Reportedly Confirms Buying Unilever’s Food Business

The Journal reported that the deal could be announced in the coming weeks.

SPDW, EFZ: Big ETF Inflows

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the SPDR Portfolio Developed World ex-US ETF, which added 22,800,000...

International ETFs to Watch as Foreign Stock Markets Beat the US

International stocks crushed U.S. markets in 2025, with ETFs such as SPDW and JIVE emerging as top plays on the global shift.

<ul class="summary-bullets"><li>CEO Thomas J. Appio said that the company is “disappointed in the results.”</li><li>The experimental therapy, however, was safe and well-tolerated, the company said.</li><li>Rifaximin is already approved in the U.S. and marketed as Xifaxan.</li></ul>Shares of Bausch Health Companies Inc. (BHC) fell 10% on Friday after the company said that its late-stage program evaluating amorphous-rifaximin solid soluble dispersion (SSD) in adults with liver cirrhosis failed to meet its primary goal.The clinical program <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.bauschhealth.com/news-releases/2026/01-23-2026-124516159">evaluated</a> rifaximin SSD for the delay of the first episode of hepatic encephalopathy (HE) in adults with liver cirrhosis who experienced no prior episodes. The program consisted of two global trials involving more than 1000 patients.Hepatic encephalopathy is a serious brain dysfunction caused by liver failure, where the liver can't remove toxins from the blood, allowing them to build up and affect the brain, causing confusion, personality changes, slurred speech, and lethargy, potentially leading to coma.<h2 class="st-heading-2">Executive Takeaway</h2>CEO Thomas J. Appio said that the company is “disappointed in the results.” The experimental therapy, however, was safe and well-tolerated, the company said.“We are currently reviewing the full dataset to determine potential new development opportunities," he said while adding that the company remains committed to bringing new treatments to patients across hepatology and other therapeutic areas.Rifaximin is already approved in the U.S. and marketed as Xifaxan which is slated to lose exclusivity in 2028. The recent trials were evaluating a new variant of the compound.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around BHC stock rose from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while retail chatter rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user expressed anticipation for the company’s quarterly report in February, saying the company “lost &nbsp;a &nbsp;Battle but not &nbsp;the &nbsp;war.”<stembedurl>https://www.stocktwits.com/Valmaro/message/642700352</stembedurl>Another user, however, opined that the trial failure is “a serious blow” to the company’s future prospects.<stembedurl>https://www.stocktwits.com/Contrarian_Dan/message/642693387</stembedurl><a href="https://stocktwits.com/symbol/BHC">BHC stock</a> has dropped 24% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-market-share-dives-in-ev-stronghold-california-in-2025-paving-way-for-asian-rivals-growth/cmUCgvWR4X8">Tesla’s Market Share Dives In EV Stronghold California In 2025, Paving Way For Asian Rival’s Growth</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Bausch Health logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

BHC Stock Plummets On Failed Liver Cirrhosis Trial: Retail Says ‘Lost Battle But Not The War’

The failed clinical program evaluated rifaximin SSD for the delay of the first episode of hepatic encephalopathy (HE) in adults with liver cirrhosis who experienced no prior episodes.

<ul class="summary-bullets"><li>The winding down of the said activities will impact about 365 employees across regions including Europe, the U.S. and China, the company said.&nbsp;</li><li>It will also result in the shut down of sites in the Netherlands, Switzerland, U.S. and China.</li><li>Galapagos CFO Aaron Cox had said in November that the company expects to be cash flow neutral to positive by the end of 2026 if the wind down is implemented.</li></ul> Galapagos NV (GLPG) on Monday announced that its Board of Directors has decided to initiate the wind-down of the company’s cell therapy activities, sending shares up 6% in Monday’s after hours trading.The company had announced its intent to wind down the activities after a strategic review and sale process in October but had held on acting on it until it completed communicating with work councils in the Belgium and Netherlands. The winding down of the said activities will impact about 365 employees across regions including Europe, the U.S. and China, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/05/3213177/0/en/Galapagos-Announces-Board-Decision-to-Initiate-Wind-Down-of-Cell-Therapy-Activities.html">said</a>.It will also result in the shut down of sites in the Netherlands, Switzerland, the U.S. and China. The U.S. facilities to be shut down include one in Princeton and another in Pittsburgh, the company said. More details about the wind down, including details pertaining to its timeline and costs, will be provided with the company’s full year earnings in February, it added.Galapagos CFO Aaron Cox had said in November that the company expects to be cash flow neutral to positive by the end of 2026 if the wind down is implemented.<h2 class="st-heading-2">Future After Wind Down</h2>On Monday, Galapagos said that the wind-down of the cell therapy activities will position it for longer-term growth. The company will continue to manage its non-cell therapy programs and evaluate all strategic alternatives for GLPG3667, an investigational, oral, selective inhibitor of tyrosine kinase 2, to accelerate its development in dermatomyositis and potentially other severe auto-immune indications, the company said.The company will also consider resuming the partnering process for the drug, it said. Galapagos also added that it will continue to maintain its presence at its headquarters in Belgium as well as its hubs in Chicago and San Francisco.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, the retail sentiment about GLPG stayed in the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<a href="https://stocktwits.com/symbol/GLPG">GLPG stock</a> has gained 15% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/toyota-us-sales-rise-8-percent-in-q4/cmxMCZPR4Ri">US Heeds Trump To Buy A Toyota: Japanese Automaker’s US Sales Rise 8% In Q4</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A logo of Galapagos, a European pharmaceutical research company, is pictured outside its facility on June 9, 2020 in Leiden, Netherlands. (Photo by Yuriko Nakao/Getty Images) 

Galapagos Stock Rises After Hours On Starting To Wind Down Cell Therapy Activities, Subsequent Workforce Reduction 

The company had announced its intent to wind down the activities after a strategic review and sale process in October.

<ul class="summary-bullets"><li>Baytex Energy announced a target of 3% to 5% annual production growth, targeted to reach about 75,000 boe/d in 2028.&nbsp;</li><li>The company said it plans to return a significant portion of Eagle Ford’s $2.14 billion in sale proceeds to shareholders.&nbsp;</li><li>It appointed Chad E. Lundberg as the President and Chief Operating Officer from Dec. 22, 2025.</li></ul>Baytex Energy Corp. (BTE) is setting the stage for growth in 2026 with a $625 million capital budget and plans to return a significant part of its Eagle Ford sale proceeds to shareholders. Additionally, the announcement of a new leadership signals a shift in priorities for the year ahead.Shares of BTE climbed over 2% in Monday's pre-market trade.<h2 class="st-heading-2">Capital Budget Usage</h2>Baytex Energy announced a capital budget of $550 to $625 million for 2026, a target of 3% to 5% production growth reaching about 75,000 barrels of oil equivalent per day (boe/d) in 2028.The company’s 2026 exploration and development budget aims to generate an average annual production of 67,000 to 69,000 boe/d and is expected to deliver 3% to 5% production growth from 2025 levels.Of this, about 55% of the budget will be allocated to light oil assets, and the remaining 45% to heavy oil assets, the company said. Production in the first quarter (Q1) of 2026 is expected to average 68,000 to 69,000 boe/d, with plans to scale to 70,000 boe/d at the end of the year. The company also plans to bring 91 heavy-oil wells onstream, with 2026 production averaging 43,000 to 44,000 bbl/d.Of the total capital expenses, $50 to $75 million growth capital will be focused on the Pembina Duvernay and northeast Alberta Mannville, $50 million will be directed towards infrastructure investment that will include anchor oil batteries and water infrastructure in the Pembina Duvernay, and gas conservation in Peace River, and another $50 million will go towards exploration and land investments, the company said."Looking ahead, we are targeting 3% to 5% annual production growth while investing in exploration and infrastructure for future development. Supported by our industry-leading net cash balance sheet, we are prioritizing shareholder returns in 2026," Eric T. Greager, Chief Executive Officer of Baytex Energy, said.<h2 class="st-heading-2">Sale Proceeds And Executive Charges</h2>Baytex Energy completed the sale of its U.S. Eagle Ford Assets for $2.14 billion on December 19, and plans to return a significant portion of the proceeds to shareholders.The company also reaffirmed its annual dividend guidance of $0.09 per share, subject to Board of Directors approval.Additionally, the energy company announced that Chad E. Lundberg will take over as President and Chief Operating Officer from Dec. 22, 2025.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around BTE stock remained in the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels at the time of writing.<figure class="image"><img style="aspect-ratio:1291/159;" src="https://news.stocktwits-cdn.com/Baytex_sentiment_png_47e2fce461.webp" alt="On Stocktwits, retail sentiment around BTE stock remained in the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels at the time of writing." width="1291" height="159"></figure>Shares of BTE have gained over 25% in the past one year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CANADA - 2025/09/17: In this photo illustration, the Baytex Energy Corp. logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Baytex Energy Sets 2026 Capital Spending, Growth Targets – And Names New COO

The company announced a capital budget of up to $625 million for 2026, with 55% allocated to light oil assets and 45% to heavy oil assets.

Retail investors on Stocktwits are optimistic about Genius Group’s pivot and hope to see the same returns as MicroStrategy after the latter pivoted to a Bitcoin-first strategy in 2020. | Source: Pixabay

Why Is Genius Group Stock Rising Today?

Genius Group repurchased its stock on the open market at an average price of $0.90 per share from August 28 to September 11, 2025.

Global Equity ETFs Draw Rising Investor Interest

Global equity funds saw $10.65B inflows as Fed rate cut bets, a weak dollar and diversification needs drive investors abroad.

SPDR Index Shares Funds - State Street SPDR Portfolio Developed World ex-US ETF

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

SPDW
SPDR Portfolio Developed World ex-US ETF

Feed

News

Sentiment

Fundamentals

Info

Latest SPDW News

SPDWSPDR Portfolio Developed World ex-US ETF